Poxel Announces Upcoming General Meeting and Document Access

Poxel SA, a clinical stage biopharmaceutical company, has announced that a Combined General Meeting will take place on December 11, 2025. The meeting will be held at the Mercure Lyon Centre Château Perrache Hotel in Lyon, France. Shareholders can access all preparatory documents through the Company’s website, in compliance with legal regulations.

Voting for the General Meeting can be conducted via mail, proxy, or electronically, starting from November 26, 2025. The secure Votacess platform will facilitate electronic voting from November 26 to December 10, 2025. Detailed voting procedures can be found in the practical guide available online.

For shareholders unable to attend the meeting in person, a live broadcast will be accessible via a link provided, although remote voting through this platform is not possible. A replay will be available after the event.